Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Around 62% of type II diabetes patients on Mounjaro continue on therapy 12 months out from their initial prescription, compared to around 45% for the same cohort of patients on Ozempic
Mechanically, Hims works through a membership: you complete an online intake, a licensed provider reviews it, and if appropriate you are prescribed a medication and enrolled in the Hims & Hers Weight Loss Membership, which bundles 24/7 provider access, ongoing clinical check-ins, personalized nutrition guidance and a member support community
Retatrutide: The New Triple-Agonist Weight Loss Treatment Medically reviewed by Dr Clair Grainger Last reviewed: 30 Dec 2025 Retatrutide is the latest weight loss medication thats currently in phase 3 clinical trials
Medicaid is different from Medicare
US$ 27.54
US$ 29.77
US$ 25.52
US$ 23.89
US$ 20.75
US$ 24.34
US$ 28.97
US$ 28.91
US$ 22.37
